Journal article icon

Journal article

The challenge of post-implementation surveillance for novel meningococcal vaccines.

Abstract:

Novel serogroup B meningococcal vaccines are currently in late stage development and may be used in mass immunisation campaigns over the coming years. This represents an exciting development in the prevention of childhood meningitis, however monitoring the impact of these vaccines on meningococcal disease epidemiology will provide significant challenges. Although designed to prevent serogroup B meningococcal disease the vaccine antigens are not serogroup specific, creating the potential for m...

Expand abstract

Actions


Access Document


Authors


Halperin, SA More by this author
Expand authors...
Journal:
Vaccine
Volume:
30 Suppl 2
Issue:
SUPPL. 2
Pages:
B67-B72
Publication date:
2012-05-05
DOI:
EISSN:
1873-2518
ISSN:
0264-410X
URN:
uuid:dd75a068-5197-4aac-803a-e4b4ba037d0c
Source identifiers:
335245
Local pid:
pubs:335245

Terms of use


Metrics



If you are the owner of this record, you can report an update to it here: Report update to this record

TO TOP